Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's Thyroid Presentation

Jarred Younger, PhD - The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 (2017 Conference) (LDN, low dose naltrexone)

People with rheumatological conditions are much more likely to have fibromyalgia than the general population, Lupus in particular was indicated to be the most likely rheumatological condition where fibromyalgia was also present. 

Kent Holtorf, MD - CFS/ME and Fibromyalgia (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's CFS/ME Presentation

Sarah Zielsdorf, MD, MS - Beyond Tired: CFS/ME or Not? (2017 Conference) (LDN, low dose naltrexone)

Dr Zielsdorf shares case studies of patients with CFS and ME and goes into the evidence showing that the hallmark of CFS/ME is a mitochondrial dysfunction and intense diet, nutritional antioxidant and other lifestyle modifications are the primary therapy for this disorder. 

Kent Holtorf, MD - Immune Modulatory Treatments for Chronic Illness (2018 Conference) (LDN, low dose naltrexone)

Elizabeth uses LDN for: Chronic Lyme Disease, CFS/ME, Food sensitivities and Cipro (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.